|Bid||106.00 x 1000|
|Ask||120.33 x 1100|
|Day's range||115.53 - 119.49|
|52-week range||105.31 - 165.03|
|Beta (5Y monthly)||1.16|
|PE ratio (TTM)||113.20|
|Earnings date||01 Aug 2022 - 05 Aug 2022|
|Forward dividend & yield||0.96 (0.82%)|
|Ex-dividend date||24 Jun 2022|
|1y target est||131.55|
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
Software revenue up 71%, total revenue up 73% year-over-yearDENVER, May 09, 2022 (GLOBE NEWSWIRE) -- Akerna (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today reported its unaudited financial results for the quarter ended March 31, 2022. "As demand for Akerna’s platforms from cannabis operators, regulators, and brands continues to widen, we
How far off is Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) from its intrinsic value? Using the most recent financial...